Financial targets

Financial targets

Bioretec updated its financial targets on May 13, 2026. To be aligned with industry reporting standards, Bioretec will transition to reporting an adjusted sales margin from Q1/2026 onwards, as compared to the previously reported sales margin.

Bioretec's updated financial targets for the strategy period 2026–2028 are:

• Reach net sales exceeding EUR 10 million by the end of the year 2028
• Maintain an average adjusted sales margin exceeding 70% during the strategy period

The targets previously announced on 16 December 2025 for the 2026–2028 strategy period were:

• Reach net sales exceeding EUR 10 million by the end of the year 2028
• Maintain an average sales margin exceeding 70% during the strategy period

Bioretec does not consider these financial targets as market guidance for any given year.

Read more about the financial targets change from this release.

Dividend policy

No dividend shall be distributed.